Skip to Main Content

Author Details

Wim Van Criekinge
Ghent University
1995
174
58
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36089502A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines.Eur Urol Oncol2023
37133554Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosis.World J Urol2023
36711686HIV-PULSE: A long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization.bioRxiv2023
36368320Challenges in neoantigen-directed therapeutics.Cancer Cell2023
36273027Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing.Sci Rep2022
35477541Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers.Clin Epigenetics2022
33356483Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria.J Urol2021
33823297Spectral Prediction Features as a Solution for the Search Space Size Problem in Proteogenomics.Mol Cell Proteomics2021
33816458DNA Methylation Regulates Transcription Factor-Specific Neurodevelopmental but Not Sexually Dimorphic Gene Expression Dynamics in Zebra Finch Telencephalon.Front Cell Dev Biol2021
33941866Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men.Prostate Cancer Prostatic Dis2021
34206969PhaLP: A Database for the Study of Phage Lytic Proteins and Their Evolution.Viruses2021
32111236Underestimated effect of intragenic HIV-1 DNA methylation on viral transcription in infected individuals.Clin Epigenetics2020
31985322A Urine Based Genomic Assay to Triage Patients with Hematuria for Cystoscopy.J Urol2020
32835812The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality.Ann Oncol2020
32282281Reply by Authors.J Urol2020
29660369Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men.Urology2019
37317474Urinary Molecular Biomarker Test Impacts Prostate Biopsy Decision Making in Clinical Practice.Urol Pract2019
31783839Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports.BMC Urol2019
30127462Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study.Prostate Cancer Prostatic Dis2019
31040227PROTEOFORMER 2.0: Further Developments in the Ribosome Profiling-assisted Proteogenomic Hunt for New Proteoforms.Mol Cell Proteomics2019
31114869MEXPRESS update 2019.Nucleic Acids Res2019
31026217Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer before Initial Prostate Biopsy.J Urol2019
30514777<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials.Clin Cancer Res2019
29140531An update on sORFs.org: a repository of small ORFs identified by ribosome profiling.Nucleic Acids Res2018
29964205Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1.Cancer Lett2018
30206342Exploratory analysis of the human breast DNA methylation profile upon soymilk exposure.Sci Rep2018
29902267Evaluation of bisulfite kits for DNA methylation profiling in terms of DNA fragmentation and DNA recovery using digital PCR.PLoS One2018
30297886A comprehensive overview of genomic imprinting in breast and its deregulation in cancer.Nat Commun2018
29666440Analysis of DNA methylation in cancer: location revisited.Nat Rev Clin Oncol2018
29713045Author Correction: Analysis of DNA methylation in cancer: location revisited.Nat Rev Clin Oncol2018
29158345Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells From Type2 Diabetes Patients: Rescue by α-Ketoglutarate and TET-TDG Functional Reactivation.Circ Res2018
29330943Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients.Prostate2018
27746284Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.J Urol2017
28370948Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics - a decision analytical model.BJU Int2017
28119363Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.Clin Cancer Res2017
28968978<i>Decoy receptor 1</i> (<i>DCR1)</i> promoter hypermethylation and response to irinotecan in metastatic colorectal cancer.Oncotarget2017
29159365Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.Ann Intern Med2017
28700459The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study.Psychosom Med2017
28853167A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.Prostate2017
28641578Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.BMC Med2017
28762545Epigenetic risk score improves prostate cancer risk assessment.Prostate2017
27982725Differential analysis of genome-wide methylation and gene expression in mesenchymal stem cells of patients with fractures and osteoarthritis.Epigenetics2017
27756787A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer Patients.Clin Cancer Res2017
28074387Epigenetic sampling effects: nephrectomy modifies the clear cell renal cell cancer methylome.Cell Oncol (Dordr)2017
26864856A genome-wide search for epigenetically [corrected] regulated genes in zebra finch using MethylCap-seq and RNA-seq.Sci Rep2016
26327355Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria.J Urol2016
26456067Forensic Loci Allele Database (FLAD): Automatically generated, permanent identifiers for sequenced forensic alleles.Forensic Sci Int Genet2016
26391330Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.Genes Chromosomes Cancer2016
27738327Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.Oncotarget2016
28066067CLINICAL EVALUATION OF AN EPIGENETIC ASSAY TO PREDICT MISSED CANCER IN PROSTATE BIOPSY SPECIMENS.Trans Am Clin Climatol Assoc2016
  • 1 - 50 of 174

Recommended Authors

Kathleen M Fisch
Center for Computational Biology and Bioinformatics, University of California
Career Start Year 2009
Number of shared co-authors 2
Harmen J G van de Werken
Department of Immunology Erasmus University Medical Center
Career Start Year 2006
Number of shared co-authors 7
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 3
Chol-Hee Jung
University of Melbourne
Career Start Year 2005
Number of shared co-authors 1
Arnaud Droit
Centre de Recherche du CHU de Quebec-Universite, Universite Laval
Career Start Year 2005
Number of shared co-authors 1
Christoph Bock
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2005
Number of shared co-authors 9
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 3
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Osvaldo Gra??a
Spanish National Cancer Research Centre-CNIO
Career Start Year 2002
Number of shared co-authors 2
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 4
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 0
Victor Segura
Center for Applied Medical Research (CIMA)
Career Start Year 2000
Number of shared co-authors 0
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 2
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 0
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 3
Steven J M Jones
University of British Columbia
Career Start Year 1995
Number of shared co-authors 7
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 1
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Aleksandar Milosavljevic
Baylor College of Medicine
Career Start Year 1991
Number of shared co-authors 2
Ivo Gut
Spain Universitat de Barcelona (UB)
Career Start Year 1991
Number of shared co-authors 7
Jean-Pierre A Kocher
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 0
Sean M Grimmond
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 3
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 12
Johan Lindberg
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 2
Jian-Bing Fan
Nanfang Hospital and Basic Medical College, Southern Medical University
Career Start Year 1987
Number of shared co-authors 4
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 2
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 25

Collaborators

Leander Van Neste
Maastricht University Medical Center
Co-authored papers 27
Manon van Engeland
Maastricht University Medical Center
Co-authored papers 20
Veerle Melotte
Maastricht University Medical Center.
Co-authored papers 11
Gerrit A Meijer
The Netherlands Cancer Institute
Co-authored papers 9
Kim M Smits
Maastricht University Medical Center+
Co-authored papers 8
Kornel E Schuebel
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health
Co-authored papers 7
Stephen B Baylin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 7
Jo Vandesompele
Co-authored papers 6
Inge M van Oort
Radboud University Medical Center
Co-authored papers 5
Dirk De Bacquer
Gent University, Gent University Hospital
Co-authored papers 5
Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Co-authored papers 4
William H Westra
Icahn School of Medicine at Mount Sinai Hospital.
Co-authored papers 4
Leslie Cope
Johns Hopkins University School of Medicine
Co-authored papers 4
Roger Stupp
Northwestern University
Co-authored papers 3
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 3
Mauro Delorenzi
Co-authored papers 2
Helai P Mohammad
Collegeville
Co-authored papers 2
Pedram Argani
The Johns Hopkins Hospital
Co-authored papers 2
Mark A van de Wiel
Amsterdam University Medical Centers (Amsterdam UMC)
Co-authored papers 2
Hanneke E C Niessen
Maastricht University Medical Center
Co-authored papers 2
Joyce E Ohm
Roswell Park Comprehensive Cancer Center
Co-authored papers 2
Rafael A Irizarry
Dana-Farber Cancer Institute
Co-authored papers 2
Remond J A Fijneman
The Netherlands Cancer Institute
Co-authored papers 2
Ewout W Steyerberg
Leiden University Medical Center
Co-authored papers 2
Joseph A Califano
University of California
Co-authored papers 2
Timothy A Chan
Cleveland Clinic.
Co-authored papers 2
Wayne Yu
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 2
Michael Weller
University Hospital and University of Zurich
Co-authored papers 2
Bruce J Trock
Johns Hopkins University School of Medicine
Co-authored papers 2
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Release 1.2